Raymond James Financial Services Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,713
| Closed | -$229K | – | 3288 |
|
|
2023
Q2 | $229K | Sell |
5,713
-69
| -1% | -$2.77K | ﹤0.01% | 2830 |
|
|
2023
Q1 | $236K | Buy |
+5,782
| New | +$236K | ﹤0.01% | 2788 |
|
|
2022
Q4 | – | Sell |
-4,749
| Closed | -$253K | – | 3285 |
|
|
2022
Q3 | $253K | Buy |
4,749
+810
| +21% | +$43.2K | ﹤0.01% | 2687 |
|
|
2022
Q2 | $230K | Sell |
3,939
-500
| -11% | -$29.2K | ﹤0.01% | 2780 |
|
|
2022
Q1 | $339K | Buy |
+4,439
| New | +$339K | ﹤0.01% | 2626 |
|
|
2021
Q3 | – | Sell |
-3,759
| Closed | -$228K | – | 3313 |
|
|
2021
Q2 | $228K | Sell |
3,759
-1,544
| -29% | -$93.7K | ﹤0.01% | 2917 |
|
|
2021
Q1 | $372K | Buy |
5,303
+1,224
| +30% | +$85.9K | ﹤0.01% | 2482 |
|
|
2020
Q4 | $244K | Sell |
4,079
-303
| -7% | -$18.1K | ﹤0.01% | 2583 |
|
|
2020
Q3 | $263K | Sell |
4,382
-2,108
| -32% | -$127K | ﹤0.01% | 2350 |
|
|
2020
Q2 | $341K | Sell |
6,490
-357
| -5% | -$18.8K | ﹤0.01% | 2155 |
|
|
2020
Q1 | $230K | Buy |
6,847
+884
| +15% | +$29.7K | ﹤0.01% | 1994 |
|
|
2019
Q4 | $270K | Buy |
+5,963
| New | +$270K | ﹤0.01% | 2383 |
|
|
2019
Q3 | – | Sell |
-5,361
| Closed | -$233K | – | 2853 |
|
|
2019
Q2 | $233K | Buy |
+5,361
| New | +$233K | ﹤0.01% | 2436 |
|
|
2019
Q1 | – | Sell |
-5,602
| Closed | -$241K | – | 2808 |
|
|
2018
Q4 | $241K | Buy |
5,602
+610
| +12% | +$26.2K | ﹤0.01% | 2138 |
|
|
2018
Q3 | $245K | Buy |
+4,992
| New | +$245K | ﹤0.01% | 2395 |
|